The GIFT Nifty futures, which is an early indicator of the Nifty50 index stocks, was trading lower by 30 points at 25,889, indicating that the domestic benchmark indices are likely to make a negative start on Tuesday. 

Earlier on Monday, 3 November, the Domestic benchmark indices S&P BSE Sensex gained by 40 points or 0.05%, and settled at 83,978, while the Nifty50 traded 0.16% higher or 41 points, closing at 25,763.

Here are some stocks that are likely to remain in focus on 3 November.

Quarterly Results Today: State Bank of India, Mahindra & Mahindra, Adani Enterprises, Indian Hotels Company, InterGlobe Aviation, Adani Ports and Special Economic Zone, One 97 Communications Paytm, One Mobikwik Systems, Aditya Birla Fashion and Retail, BlueStone Jewellery and Lifestyle, Chalet Hotels, Escorts Kubota, Alembic Pharmaceuticals, Berger Paints India, Metropolis Healthcare, Nuvama Wealth Management, Suzlon Energy, and Escorts Kubota are some of the prominent companies set to announce their quarterly earnings for July-September.

Cipla: Cipla has signed an agreement to acquire 100% of Inzpera Healthsciences Ltd for Rs 110.65 crore, making Inzpera a wholly owned subsidiary after the deal’s completion. The acquisition reinforces Cipla’s strategy to expand and strengthen its consumer healthcare portfolio, particularly in the wellness and nutrition segment.

Lemon Tree Hotels: Lemon Tree Hotels has expanded its presence in Uttarakhand with the launch of its ninth property in the state, Lemon Tree Hotel, Mall of Dehradun. The newly opened hotel features 98 rooms and is managed by its subsidiary, Carnation Hotels, further boosting the company’s hospitality footprint in key leisure and business destinations.

Indus Towers: Bharti Airtel’s board has approved plans to acquire up to an additional 5% stake in its subsidiary Indus Towers Ltd. The acquisition may occur in multiple tranches and is designed to strengthen Airtel’s strategic position in the telecom infrastructure space. Airtel said it will continue exploring opportunities to increase its stake in Indus Towers while maintaining healthy cash flow for expansion and shareholder returns.

Zydus Lifesciences: Zydus Lifesciences announced that its board will meet on 6 November to consider raising up to Rs 5,000 crore through instruments such as a Qualified Institutional Placement (QIP), rights issue, or private placement. The capital-raising proposal, which will need shareholder approval via postal ballot, aims to support the company’s expansion plans and strategic initiatives.

The future of investing is here!
Unicorn Signals leverages advanced AI technology to provide you with powerful market predictions and actionable stock scans. Download the app todayand 10x your trading & investing journey!